Editorial ☆
Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status ☆
Curb challenges of the “Trojan Horse” approach: Smart strategies in achieving effective yet safe cell-penetrating peptide-based drug delivery ☆
Expand classical drug administration ways by emerging routes using dendrimer drug delivery systems: A concise overview ☆
Fatty acids as therapeutic auxiliaries for oral and parenteral formulations ☆
Intestinal drug transporters: An overview ☆
Fusion protein linkers: Property, design and functionality ☆
Amino acids as promoieties in prodrug design and development ☆
Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant ☆